Hasan Rizvi
Queen Mary University of London(GB)Barts Health NHS Trust(GB)Royal London Hospital(GB)Hamad Medical Corporation(QA)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Rheumatoid Arthritis Research and Therapies, Nonmelanoma Skin Cancer Studies, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis(2014)350 cited
- → Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial(2021)295 cited
- → Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial(2022)251 cited
- → Value of scintigraphy in chronic peritoneal dialysis patients(1999)63 cited
- → Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials(2023)57 cited
- → B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure